Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
Public ClinicalTrials.gov record NCT01147003. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Study identification
- NCT ID
- NCT01147003
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis
- Industry
- Enrollment
- 93 participants
Conditions and interventions
Conditions
Interventions
- Investigational new drug, company code: BGG492 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2010
- Primary completion
- Aug 31, 2011
- Completion
- Aug 31, 2011
- Last update posted
- Dec 16, 2020
2010 – 2011
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Clinics at St. Joseph's Hospital and MC | Phoenix | Arizona | 85013 | — |
| Center for Neurosciences | Tucson | Arizona | 85718 | — |
| Clinical Trials, Inc. | Little Rock | Arkansas | 72205 | — |
| Medical Center of the Rockies | Loveland | Colorado | 80538 | — |
| AMO Corporation | Tallahassee | Florida | 32308 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| Investigative Site - Private Practice | Ocean Springs | Mississippi | 39564 | — |
| St.John's Research Institute, Inc | Springfield | Missouri | 65804 | — |
| Renown Institute for Neurosciences | Reno | Nevada | 89521 | — |
| NJ to Capital Health in Hamilton | Somerset | New Jersey | 08873 | — |
| Princeton and Rutgers Neurology | Somerset | New Jersey | 08873 | — |
| NYU Comprehensive Epilepsy Center | New York | New York | 10016 | — |
| Thomas Jefferson University, Dept. of Psychiatry & Neurology | Philadelphia | Pennsylvania | 19107 | — |
| Neurological Clinic of Texas | Dallas | Texas | 75230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01147003, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01147003 live on ClinicalTrials.gov.